Evidence map›Paper›PMID 42487665›Full record

ArticleACS catalysis2025

Highly Enantioselective Construction of Oxazolidinone Rings via Enzymatic C(sp

Jadab Majhi, Satyajit Roy, Anwita Chattopadhyay, Rudi Fasan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS catalysis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jadab MajhiDepartment of Chemistry and Biochemistry, The University of Texas at Dallas, 800 W. Campbell Road, Richardson, TX 75080, United States.ORCID 0000-0001-8600-304X
Satyajit RoyDepartment of Chemistry and Biochemistry, The University of Texas at Dallas, 800 W. Campbell Road, Richardson, TX 75080, United States.ORCID 0000-0001-7374-4797
Anwita ChattopadhyayDepartment of Chemistry and Biochemistry, The University of Texas at Dallas, 800 W. Campbell Road, Richardson, TX 75080, United States.ORCID 0000-0003-1294-7552
Rudi FasanDepartment of Chemistry and Biochemistry, The University of Texas at Dallas, 800 W. Campbell Road, Richardson, TX 75080, United States.ORCID 0000-0003-4636-9578

Funding

Selective P450 Oxidation Catalysts for Synthesis of Bioactive MoleculesR01GM098628 · NIGMS · UNIVERSITY OF TEXAS DALLAS · PI FASAN, RUDI · 2012 to 2024
$4.7M
NIGMS NIH HHS R01 GM098628
6 · The paper itself

Abstract

Oxazolidinones are important heterocycles widely utilized in medicinal chemistry for the synthesis of antifungals, antibacterials, and other bioactive compounds and in organic chemistry as chiral auxiliaries for asymmetric synthesis. Herein, we report a biocatalytic strategy for the synthesis of enantioenriched oxazolidinones through the intramolecular C(sp

Indexed as

BiocatalysisCarbamate derivativesC-H AminationMyoglobinNitrene TransferOxazolidinones

Identifiers

PMID42487665
PMCPMC13390897

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.